Preparation and Physicochemical Evaluation of Oral Disintegrated Tablet Containing Dicyclomine Hydrochloride
Authors
Abstract
Dicyclomine hydrochloride is anticholinergic used as an anti-spasmodic drug. The aim of this study was to prepare hard and fast oral disintegrating tablets (ODTs) containing Dicyclomine hydrochloride which can release drug at the least possible time. The ODTs serve as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for increasing the patient compliance. The ODTs were prepared using croscarmellose, crospovidone, and mallow mucilage as superdisintegrants. Tablets formulated by direct compression method and various parameters were evaluated. Based on disintegration time and hardness of tablets, two types of superdisintegrants (mallow mucilage and croscarmelose) selected and different ODTs containing combination of two superdisintegrant were prepared. Angle of repose and Carr’s index of tested powders were in the range of 27.3 to 30.1 and 9.3 to 23.91 respectively. These findings indicated that the powder prepared possessed appropriate flow properties. The ODTs of dicyclomine showed uniform content and low weight variation. Friability percent was below 0.8%, which was in acceptable limit. The tablet formulations contained mucilage at concentrations of 3.3-5% in combination with croscarmelose showed lower disintegration time as compared to those containing mucilage alone. Formulation containing 5% mucilage and 3.3% croscarmelose identified as optimum formulation because of lowest disintegration time, acceptable drug release time and appropriate hardness.
Highlights
Copyright
© 2018, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Formulation and Evaluation of Co-Amoxiclav 228 and 312 mg Dispersible Tablets
Aslani A, Fathi A. Formulation and Evaluation of Co-Amoxiclav 228 and 312 mg Dispersible Tablets. J Rep Pharm Sci. 2016;5(1):e147656. doi:
Formulation and Evaluation of Taste Masked Mouth Dissolving Tablets of Levocetirizine Hydrochloride
Sharma V, Chopra H. Formulation and Evaluation of Taste Masked Mouth Dissolving Tablets of Levocetirizine Hydrochloride. Iran J Pharm Res. 2012;11(2):e125859. doi: https://doi.org/10.22037/ijpr.2011.1032
In vitro Release Kinetics Study of Diltiazem Hydrochloride from Wax and Kollidon SR Based Matrix Tablets
Islam MS, Reza S, Rahman H. In vitro Release Kinetics Study of Diltiazem Hydrochloride from Wax and Kollidon SR Based Matrix Tablets. Iran J Pharm Res. 2022;7(2):e128577. doi: https://doi.org/10.22037/ijpr.2010.751
The Release Behavior and Kinetic Evaluation of Diltiazem HCl from Various Hydrophilic and Plastic Based Matrices
Mehrgan H, Mortazavi SA. The Release Behavior and Kinetic Evaluation of Diltiazem HCl from Various Hydrophilic and Plastic Based Matrices. Iran J Pharm Res. 2022;4(3):e128237. doi: https://doi.org/10.22037/ijpr.2010.629
Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
Tayebi H, Mortazavi SA. Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet. Iran J Pharm Res. 2011;10(3):e125934. doi: https://doi.org/10.22037/ijpr.2011.946
More by these authors
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 1
Last Update: 2 weeks ago
- Scopus by Title (Ref): 1
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 2 days ago